ALLERGY MULTI SYMPTOM (Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl) Tablet, Film Coated Salado Sales, Inc.

Updated Date: Thu, 17 Oct 2019 00:00:00 EDT
Source: DailyMed Drug Label Updates - Category: Drugs & Pharmacology Source Type: alerts

Related Links:

Condition:   Peanut Allergy Interventions:   Drug: INP20;   Drug: Placebo Sponsors:   InnoUp Farma S.L.;   Syntax for Science, S.L Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Allergic Rhinitis Intervention:   Drug: BAY76-2211 (Loratadine) Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Vaginal delivery and breastfeeding lessen the number of new allergy and asthma cases in children up to the age of 18 years, according to new research.
Source: WebMD Health - Category: Consumer Health News Source Type: news
This study aimed to delineate the causal relation between GERD and asthma.MethodsParticipants of the Korean National Health Insurance Service-National Sample Cohort 2002-2013 who were ≥ 20 years old were selected for this study. In study I, 116,502 GERD patients were matched in a 1:2 ratio to 233,004 control I participants, and the hazard ratio (HR) of asthma in GERD patients was analyzed. In study II, 104,146 asthma patients were matched in a 1:1 ratio to 104,146 control II participants, and the HR for GERD in asthma patients was analyzed. A stratified Cox-proportional hazards model was used. Subgroup analyses were per...
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Publication date: Available online 13 November 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Dr. Ivan D. Cardona, Dr. Erin E. Kempe, Dr. Christine Lary, Ms. Julia H. Ginder, Dr. Neal JainAbstractBackgroundStudies evaluating bathing frequency in pediatric atopic dermatitis (AD) are limited. Parents of children with AD often receive conflicting information, leading to frustration and confusion.ObjectiveTo evaluate efficacy of twice-daily, soaking baths, followed by immediate application of an occlusive moisturizer (i.e. soak-and-seal [SS]), versus twice-weekly SS baths, in the acute manage...
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
Most people aren't aware they can trigger allergy-like symptoms and serious infections such as pneumonia, according to Manal Mohammed, a lecturer in microbiology at Westminster University.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Researchers from Stanford University in California, found almost three quarters of people who had the injection could eat the equivalent of an entire nut a fortnight later.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
By Elizabeth Cohen and Nadia Kounang, CNN (CNN) — Every 15 minutes, someone in the United States dies of a superbug that has learned to outsmart even our most sophisticated antibiotics, according to a new report from the US Centers for Disease Control and Prevention. That’s about 35,000 deaths each year from drug-resistant infections, according to the landmark report. The report places five drug-resistant superbugs on the CDC’s “urgent threat” list — two more germs than were on the CDC’s list in 2013, the last time the agency issued a report on antibiotic resistance. Gene...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Syndicated CBSN Boston Antibiotics CNN Source Type: news
THURSDAY, Nov. 14, 2019 -- People with peanut allergy must be constantly vigilant to avoid a life-threatening allergic reaction. But researchers report that a new drug injection might offer at least temporary protection against the most severe...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Publication date: December 2019Source: Molecular Immunology, Volume 116Author(s): Tomoya Takashima, Tomoki Taku, Tomoka Yamanaka, Tamo Fukamizo, Tomoyuki Numata, Takayuki OhnumaAbstractA 38 kDa β-1,3-glucanase allergen from Cryptomeria japonica pollen (CJP38) was recombinantly produced in E. coli and purified to homogeneity with the use of Ni-affinity resin. CJP38 hydrolyzed β-1,3-glucans such as CM-curdlan and laminarioligosaccharides in an endo-splitting manner. The optimum pH and temperature for β-1,3-glucanase activity were approximately 4.5 and 50 °C, respectively. The enzyme was stabl...
Source: Molecular Immunology - Category: Allergy & Immunology Source Type: research
More News: Acetaminophen | Allergy | Allergy & Immunology | Drugs & Pharmacology | Lortab